ExploreWatchlistsPricing
  1. US-listed companies
  2. Q BioMed Inc.
  3. Financials
  4. Cash from operations

Q BioMed Inc. (QBIO)

Market cap
$144.09
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Nov 30, 20222-145.13%
Nov 30, 2021-4-30.98%
Nov 30, 2020-6+51.85%
Nov 30, 2019-4-36.36%
Nov 30, 2018-6+15.51%
Nov 30, 2017-6+261.39%
Nov 30, 2016-2+4037.13%
Nov 30, 2014-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat